Document ID: chunk:federal_register_of_legislation:F2024C00836:clause:1_1:p2
Version: federal_register_of_legislation:F2024C00836
Segment Type: clause
Provision Reference: sch 1 cl 1 (pt 2/2)
Character Range: 10182–11745

= repealed and substituted
F = Federal Register of Legislation             s = section(s)/subsection(s)
gaz = gazette                                   Sch = Schedule(s)
LA = Legislation Act 2003                       Sdiv = Subdivision(s)
LIA = Legislative Instruments Act 2003          SLI = Select Legislative Instrument
(md not incorp) = misdescribed amendment        SR = Statutory Rules
cannot be given effect                          Sub‑Ch = Sub‑Chapter(s)
mod = modified/modification                     SubPt = Subpart(s)
No. = Number(s)                                 underlining = whole or part not
o = order(s)                                    commenced or to be commenced
Ord = Ordinance

Endnote 3—Legislation history

Name                                                                         Registration       Commencement       Application, saving and transitional provisions
Therapeutic Goods (Clinical Trial Inspections) Specification (No. 2) 2020    13 August 2020     14 August 2020     —
                                                                             (F2020L01017)
Therapeutic Goods (Clinical Trial Inspections) Amendment Specification 2024  18 September 2024  19 September 2024  —
                                                                             (F2024L01177)

Endnote 4—Amendment history

Provision affected    How affected
s 2………………………………..     rep LA s 48D
s 4………………………………..     am F2024L01177
s 6………………………………..     rep LA s 48C
Schedule 1……………………….  am F2024L01177
Schedule 2……………………….  rep LA s 48C